Literature DB >> 2505252

Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.

D C Hill-Eubanks1, C G Parker, P Lollar.   

Abstract

Blood coagulation factor VIII (fVIII) is a plasma protein that is decreased or absent in hemophilia A. It is isolated as a mixture of heterodimers that contain a variably sized heavy chain and a common light chain. Thrombin catalyzes the activation of fVIII in a reaction that is associated with cleavages in both types of chain. We isolated a serine protease from Bothrops jararacussu snake venom that catalyzes thrombin-like heavy-chain cleavage but not light-chain cleavage in porcine fVIII as judged by NaDodSO4/PAGE and N-terminal sequence analysis. Using a plasma-free assay of the ability of activated fVIII to function as a cofactor in the activation of factor X by factor IXa, we found that fVIII is activated by the venom enzyme. The venom enzyme-activated fVIII was isolated in stable form by cation-exchange HPLC. von Willebrand factor inhibited venom enzyme-activated fVIII but not thrombin-activated fVIII. These results suggest that the binding of fVIII to von Willebrand factor depends on the presence of an intact light chain and that activated fVIII must dissociate from von Willebrand factor to exert its cofactor effect. Thus, proteolytic activation of fVIII-von Willebrand factor complex appears to be differentially regulated by light-chain cleavage to dissociate the complex and heavy-chain cleavage to activate the cofactor function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505252      PMCID: PMC297873          DOI: 10.1073/pnas.86.17.6508

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.

Authors:  P Lollar; C G Parker; P J Kajenski; R D Litwiller; D N Fass
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

3.  Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).

Authors:  D D Pittman; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 4.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.

Authors:  W H Kane; E W Davie
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

5.  Human von Willebrand factor: a multivalent protein composed of identical subunits.

Authors:  M W Chopek; J P Girma; K Fujikawa; E W Davie; K Titani
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

6.  Association of the factor VIII light chain with von Willebrand factor.

Authors:  P Lollar; D C Hill-Eubanks; C G Parker
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

7.  An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor.

Authors:  P A Foster; C A Fulcher; R A Houghten; T S Zimmerman
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

8.  Molecular characterization of commercial porcine factor VIII concentrate.

Authors:  P Lollar; C G Parker; R P Tracy
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

9.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.

Authors:  R J Kaufman; L C Wasley; A J Dorner
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

10.  Stoichiometry of the porcine factor VIII-von Willebrand factor association.

Authors:  P Lollar; C G Parker
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  18 in total

Review 1.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Crystal structure of Jararacussin-I: the highly negatively charged catalytic interface contributes to macromolecular selectivity in snake venom thrombin-like enzymes.

Authors:  A Ullah; T A C B Souza; L M Zanphorlin; R B Mariutti; V S Santana; M T Murakami; R K Arni
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

3.  Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.

Authors:  R De Cristofaro; V De Filippis
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

4.  Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.

Authors:  Marco Campos; Ashley Buchanan; Fuli Yu; Maja Barbalic; Yang Xiao; Lloyd E Chambless; Kenneth K Wu; Aaron R Folsom; Eric Boerwinkle; Jing-fei Dong
Journal:  Blood       Date:  2012-01-04       Impact factor: 22.113

5.  High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.

Authors:  Christina Hausl; Rafi U Ahmad; Maria Sasgary; Christopher B Doering; Pete Lollar; Günter Richter; Hans Peter Schwarz; Peter L Turecek; Birgit M Reipert
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

6.  A bipartite autoinhibitory region within the B-domain suppresses function in factor V.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

7.  Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies.

Authors:  Justin D Walter; Rachel A Werther; Maria S Polozova; Julie Pohlman; John F Healey; Shannon L Meeks; Pete Lollar; P Clint Spiegel
Journal:  J Biol Chem       Date:  2013-02-15       Impact factor: 5.157

8.  The influence of von Willebrand factor on factor VIII activity measurements.

Authors:  S Butenas; B Parhami-Seren; K G Mann
Journal:  J Thromb Haemost       Date:  2008-10-29       Impact factor: 5.824

Review 9.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

10.  The diversity of the immune response to the A2 domain of human factor VIII.

Authors:  Rebecca C Markovitz; John F Healey; Ernest T Parker; Shannon L Meeks; Pete Lollar
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.